Source: Virtual Congress 2020 – Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. Paone (Roma (RM), Italy), G. De Rose (Roma (RM), Italy), D. Pellegrino (Roma (RM), Italy), G. Lucantoni (Roma (RM), Italy), I. Cuccaro (Roma (RM), Italy), I. Menichini (Roma (RM), Italy), G. Leodori (Roma (RM), Italy), C. Pellicano (Roma (RM), Italy), A. Sebastiani (Roma (RM), Italy), E. Rosato (Roma (RM), Italy), P. Palange (Roma (RM), Italy). Comparison among BAL biomarkers in ILD discrimination and course prediction. 1081

Member's Comments

No comment yet.

Related content which might interest you: Crossing the divide between clinical BOS risk prediction and proteomic BALF biomarkers Source: Annual Congress 2010 - Mechanisms of late allograft dysfunction: new insights Year: 2010 Simultaneous analysis of clinical markers for predicting increased lung function fluctability in stable asthma Source: Annual Congress 2012 - Clinical aspects and treatment of asthma and allergic respiratory diseases Year: 2012 Differences in plasma and sputum biomarkers between COPD and COPD-asthma overlap Source: Annual Congress 2013 –Is it really asthma? Year: 2013 Assessment of airway pathology in COPD patients by a visual endoscopic scoring system and its relation to BAL, sputum and lung function Source: Eur Respir J 2002; 20: Suppl. 38, 403s Year: 2002 Concordance analysis of cells present in bronchoalveolar lavage in patients with interstitial lung diseases by type of readings and pulmonary location Source: International Congress 2017 – ILDs: clinical problems Year: 2017 The relationship between the course of sarcoidosis and changes of markers of the disease activity in a bronchoalveolar lavage fluid Source: Eur Respir J 2002; 20: Suppl. 38, 469s Year: 2002 Predictive variables to obtain a bronchoalveolar lavage of adequate quality in patients with interstitial lung diseases Source: International Congress 2019 – Interventional pulmonology: diagnostic techniques and obstructive airway disease Year: 2019 Is the severity of newly diagnosed pulmonary sarcoidosis reflected by bronchoalveolar lavage (BAL) parameters? Source: Eur Respir J 2001; 18: Suppl. 33, 507s Year: 2001 Is the severity of newly diagnosed pulmonary sarcoidosis reflected by bronchoalveolar lavage (BAL) parameters? Source: Eur Respir J 2002; 20: Suppl. 38, 468s Year: 2002 Simultaneous analysis of sputum and serum biomarkers in adult asthma Source: International Congress 2019 – Clinical implications of asthma management Year: 2019 Differences in plasma and sputum biomarkers between COPD and COPD–asthma overlap Source: Eur Respir J 2014; 43: 421-429 Year: 2013 Elevated levels of chemokines in bronchoalveolar lavage fluid as diagnostic markers for predicting the development of post-transplant obliterative bronchiolitis Source: Eur Respir J 2001; 18: Suppl. 33, 180s Year: 2001 Sampling the lung fluids: peripheral biomarkers Source: Annual Congress 2007 - Pulmonary biomarkers in COPD Year: 2007 Proteomic analysis of sputum from adults with cystic fibrosis and COPD: identification of potential biomarkers for disease monitoring Source: Eur Respir J 2006; 28: Suppl. 50, 152s Year: 2006 Relationship of airway structural changes and lung function abnormalities with blood and BAL biomarkers in asthma Source: International Congress 2019 – Lung function evaluation and prognosis of airway diseases Year: 2019 Comparison of different staging methods for COPD in predicting outcomes Source: Eur Respir J, 51 (3) 1700577; 10.1183/13993003.00577-2017 Year: 2018 Automatic quantitative fibrosis scores at baseline is a predictor of progression in patients with IPF Source: International Congress 2017 – Idiopathic pulmonary fibrosis (IPF): clinical problems Year: 2017 Predictive value of multiorgan imaging biomarkers for predicting exacerbations in COPD patients Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018 KL-6 is a useful serum biomarker for early detection of interstitial lung disease Source: Annual Congress 2012 - Diffuse parenchymal lung disease pathogenesis, biomarkers, therapy and new entities Year: 2012 Utility of assessing CMV specific reactivity in BAL Source: Annual Congress 2010 - New clinical and experimental insights in lung transplantation Year: 2010